// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Evaluation of Site Versus Central Assessment of Endoscopies in Crohn's Disease: Comparison Using Data From EXTEND

Walter Reinisch - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Adalimumab

Effects of Continued Vedolizumab Therapy for Crohn's Disease in Week 6 Induction Therapy Nonresponders

Brian G. Feagan - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

Entyvio

Patient-Reported Symptom Measures Differ in Their Association With Mucosal Healing in Adults With Moderately to Severely Active Ulcerative Colitis: Results From ULTRA 1 and 2

William Sandborn - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ulcerative colitis

Adalimumab

Serum Golimumab Exposure and the Incidence of Selected Safety Events in Patients With Ulcerative Colitis Following Treatment With Golimumab: an Exploratory Analysis of the Pursuit Study Data

Zhenhua Xu - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

golimumab

Adalimumab Maintains Remission for Up to 4 Years in Patients With Ulcerative Colitis

William Sandborn - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Ulcerative colitis

Adalimumab

Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Pursuit-SC Maintenance Study Extension

Walter Reinisch - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ulcerative colitis

golimumab

Do Genetic Markers Predict a Progressive Disease Course in Crohn's Disease?

Krzysztof Borowski - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

N/A

Resected Fibrostenotic Intestine From Crohn's Disease Patients Express Significant TNF in Proliferative Fibroblasts and in Extracellular Matrix

Xianyong Gui - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Crohn's disease

N/A

Has the Time to First Abdominal Surgery for Crohn's Disease Reduced With Early Immunosuppressant Therapy?

Krzysztof Borowski - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Anal fistula

N/A

Impact of Inflammatory Bowel Disease Activity on the Incidence of Non-Alcoholic Fatty Liver Disease: a 7-Year Longitudinal Study

Kathleen C. Rollet - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

N/A

Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease

David Kevans - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Anal fistula

N/A

Gastric-Retentive Transcutaneous Intraluminal Impedance Measurement (TIIM): Sham Controlled, Minimally-Invasive Assessment of Gastric Motility in Acute Canine Models

Michael D. Poscente - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Neostigmine

Prediction of Retained Common Bile Duct Stones (Rcbds) in Acute Biliary Pancreatitis: Evaluation of Laboratory Testing According to Time

Jean-Daniel Baillargeon - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Pancreatitis

Alkaline phosphatase

Feasability, Safety, Short and Long-Term Outcomes of EUS-Guided Drainage of Pancreatic Fluid Collections Without Fluoroscopy or Anesthesia Support

Sarto C. Paquin - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Midazolam

Gastrointestinal Stromal Tumors: a Systematic Review of Diagnostic Yield and Complication Rates of Endoscopic Ultrasound Fine Needle Biopsy

Mohammed AlAwamy - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gastrointestinal stromal tumor

N/A

Endoscopic Ultrasound Guided Liver Biopsy for Parenchymal Disease: a Comparison of Diagnostic Yield Between Two Needles

Mohammad A. Al-Haddad - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Fatty Liver Disease

N/A

Clinical Impact of Longer Battery Life in Small Bowel Capsule Endoscopy: a Single-Center Experience

Oliver Takach - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Should We Still BE Performing Open Appendectomies? a Comparison of Outcomes for Laparoscopic Versus Open Appendectomy With Data From the Canadian Institute for Health Information (CIHI)

Divine Tanyingoh - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is Early Discharge Following Elective Surgery for Colon Cancer Safe? an Analysis of Short-Term Outcomes

Timothy Jackson - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

CDK10, a Potential Predictive Biomarker for Colorectal Cancer, Is Involved in BCL-2 and BCL-XL Mediated-Resistance to Apoptosis

Mohammad Hasan - Digestive Disease Week (DDW) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Copyright © 2026. QuantiNova All rights reserved